| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf3fbfb240fe74dbed641d4108150f96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7ced3dc7e8638995d10d442c97abda57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b3250b1ab895afda6e0dbcfc1f5923f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3a93ef6cec291128c6f1b5173e3f6036 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-91 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-735
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0072 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-08 |
| filingDate |
2011-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24b961b77df5b90221c85787137b981f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93cbe089a9ca1ddd2e7f5dbe6228f400
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b59ac46349d098e15bb5ef466321c230 |
| publicationDate |
2012-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2012053776-A9 |
| titleOfInvention |
Hyaluronic acid compounds, method for preparing same, and use thereof |
| abstract |
The present invention relates to hyaluronic acid compounds, to a method for preparing same and to the use thereof. A soft-tissue filler containing the hyaluronic acid compounds of the present invention has a longer biodegradation rate than those of conventional soft-tissue fillers using crosslinked hyaluronic acid gels. Retinoic acid components of the hyaluronic acid compounds of the present invention provide a collagen-producing ability, and the produced collagen maintains the skin elasticity of a user even when the filler biodegrades, to thus significantly reduce the necessity of re-injecting a soft-tissue filler into the soft tissue to which the soft-tissue filler is applied. The soft-tissue filler containing the hyaluronic acid compounds of the present invention is advantageous in that it has superior treatment effects, is natural, and maintains the effects thereof over a long period of time. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10414833-B2 |
| priorityDate |
2010-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |